BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 19838783)

  • 21. Phylogenetic and functional analysis of sequence variation of human papillomavirus type 31 E6 and E7 oncoproteins.
    Ferenczi A; Gyöngyösi E; Szalmás A; László B; Kónya J; Veress G
    Infect Genet Evol; 2016 Sep; 43():94-100. PubMed ID: 27197052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel effect of the high risk-HPV E7 CKII phospho-acceptor site on polarity protein expression.
    Dizanzo MP; Bugnon Valdano M; Basukala O; Banks L; Gardiol D
    BMC Cancer; 2022 Sep; 22(1):1015. PubMed ID: 36153517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus.
    Braakhuis BJ; Snijders PJ; Keune WJ; Meijer CJ; Ruijter-Schippers HJ; Leemans CR; Brakenhoff RH
    J Natl Cancer Inst; 2004 Jul; 96(13):998-1006. PubMed ID: 15240783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of miRNAs dysregulated in human foreskin keratinocytes (HFKs) expressing the human papillomavirus (HPV) Type 16 E6 and E7 oncoproteins.
    Yablonska S; Hoskins EE; Wells SI; Khan SA
    Microrna; 2013; 2(1):2-13. PubMed ID: 25070710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Computational and AI-driven 3D structural analysis of human papillomavirus (HPV) oncoproteins E5, E6, and E7 reveal significant divergence of HPV E5 between low-risk and high-risk genotypes.
    Jones RN; Miyauchi S; Roy S; Boutros N; Mayadev JS; Mell LK; Califano JA; Venuti A; Sharabi AB
    Virology; 2024 Feb; 590():109946. PubMed ID: 38147693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity.
    Hebner CM; Laimins LA
    Rev Med Virol; 2006; 16(2):83-97. PubMed ID: 16287204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human papillomavirus type 16 E6 and E7 oncoproteins interact with the nuclear p53-binding protein 1 in an in vitro reconstructed 3D epithelium: new insights for the virus-induced DNA damage response.
    Squarzanti DF; Sorrentino R; Landini MM; Chiesa A; Pinato S; Rocchio F; Mattii M; Penengo L; Azzimonti B
    Virol J; 2018 Nov; 15(1):176. PubMed ID: 30445982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human Papillomavirus Genotypes and HPV16 E6/E7 Variants among Patients with Genital Cancers in Vietnam.
    Pham TTT; Bi X; Hoang HTT; Ishizaki A; Nguyen MTP; Nguyen CH; Nguyen HP; Pham TV; Ichimura H
    Jpn J Infect Dis; 2018 Nov; 71(6):419-426. PubMed ID: 29962490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human papillomaviruses in epigenetic regulations.
    Durzynska J; Lesniewicz K; Poreba E
    Mutat Res Rev Mutat Res; 2017; 772():36-50. PubMed ID: 28528689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular interactions of 'high risk' human papillomaviruses E6 and E7 oncoproteins: implications for tumour progression.
    Chakrabarti O; Krishna S
    J Biosci; 2003 Apr; 28(3):337-48. PubMed ID: 12734411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel Functions of the Human Papillomavirus E6 Oncoproteins.
    Wallace NA; Galloway DA
    Annu Rev Virol; 2015 Nov; 2(1):403-23. PubMed ID: 26958922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human Papillomaviruses as Infectious Agents in Gynecological Cancers. Oncogenic Properties of Viral Proteins.
    Haręża DA; Wilczyński JR; Paradowska E
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis.
    zur Hausen H
    J Natl Cancer Inst; 2000 May; 92(9):690-8. PubMed ID: 10793105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of human papillomaviruses in carcinogenesis.
    Ghittoni R; Accardi R; Chiocca S; Tommasino M
    Ecancermedicalscience; 2015; 9():526. PubMed ID: 25987895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The human papillomavirus type 16 E6 and E7 oncoproteins dissociate cellular telomerase activity from the maintenance of telomere length.
    Stöppler H; Hartmann DP; Sherman L; Schlegel R
    J Biol Chem; 1997 May; 272(20):13332-7. PubMed ID: 9148955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells.
    He H; Liu X; Liu Y; Zhang M; Lai Y; Hao Y; Wang Q; Shi D; Wang N; Luo XG; Ma W; Zhang TC
    J Virol; 2019 Apr; 93(8):. PubMed ID: 30728257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of E6/E7-Dependent MicroRNAs in HPV-Positive Cancer Cells.
    Honegger A; Schilling D; Sültmann H; Hoppe-Seyler K; Hoppe-Seyler F
    Methods Mol Biol; 2018; 1699():119-134. PubMed ID: 29086374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Papillomavirus E6 and E7 proteins and their cellular targets.
    Wise-Draper TM; Wells SI
    Front Biosci; 2008 Jan; 13():1003-17. PubMed ID: 17981607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptional regulation of genes involved in keratinocyte differentiation by human papillomavirus 16 oncoproteins.
    Gyöngyösi E; Szalmás A; Ferenczi A; Póliska S; Kónya J; Veress G
    Arch Virol; 2015 Feb; 160(2):389-98. PubMed ID: 25488293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-risk HPV oncoproteins E6 and E7 and their interplay with the innate immune response: Uncovering mechanisms of immune evasion and therapeutic prospects.
    Lo Cigno I; Calati F; Girone C; Catozzo M; Gariglio M
    J Med Virol; 2024 Jun; 96(6):e29685. PubMed ID: 38783790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.